This focused review highlights the importance of yes-associated protein (YAP)/transcriptional coactivator with PDZ binding motif (TAZ) mechanosignaling in human trabecular meshwork and Schlemm's canal cells in response to glaucoma-associated extracellular matrix stiffening and cyclic mechanical stretch, as well as biochemical pathway modulators (with signaling crosstalk) including transforming growth factor beta 2, glucocorticoids, Wnt, lysophosphatidic acid, vascular endothelial growth factor, and oxidative stress. We provide a comprehensive overview of relevant literature from the last decade, highlight intriguing research avenues with translational potential, and close with an outlook on future directions.
Keyphrases
- vascular endothelial growth factor
- extracellular matrix
- transforming growth factor
- oxidative stress
- endothelial cells
- induced apoptosis
- epithelial mesenchymal transition
- bone mineral density
- cell cycle arrest
- systematic review
- cell proliferation
- single cell
- small molecule
- stem cells
- dna damage
- gene expression
- signaling pathway
- transcription factor
- induced pluripotent stem cells
- cell therapy
- current status
- pluripotent stem cells
- diabetic rats
- ischemia reperfusion injury
- postmenopausal women
- dna binding
- bone marrow
- human health
- optic nerve
- body composition
- risk assessment
- cataract surgery
- heat shock protein